Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMH-CIDI) by Kessler, Ronald C. et al.
122 International Journal of Methods in Psychiatric Research, Volume 13, Number 2
Clinical calibration of DSM-IV diagnoses in
the World Mental Health (WMH) version of
the World Health Organization (WHO)
Composite International Diagnostic
Interview (WMH-CIDI)
RONALD C. KESSLER,1 JAMIE ABELSON,2 OLGA DEMLER,1 JAVIER I. ESCOBAR,3 MIRIAM
GIBBON,4 MARGARET E. GUYER,1 MARY J. HOWES,1 ROBERT JIN,1 WILLIAM A. VEGA,3
ELLEN E. WALTERS,1 PHILIP WANG,1 ALAN ZASLAVSKY,1 HUI ZHENG1
1 Department of Health Care Policy, Harvard Medical School, Boston MA, USA
2 Institute for Social Research, University of Michigan, Ann Arbor MI, USA 
3 University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick
NJ, USA
4 New York State Psychiatric Institute, New York City NY, USA 
ABSTRACT An overview is presented of the rationale, design, and analysis plan for the WMH-CIDI clinical 
calibration studies. As no clinical gold standard assessment is available for the DSM-IV disorders assessed in the
WMH-CIDI, we adopted the goal of calibration rather than validation; that is, we asked whether WMH-CIDI 
diagnoses are ‘consistent’ with diagnoses based on a state-of-the-art clinical research diagnostic interview (SCID;
Structured Clinical Interview for DSM-IV) rather than whether they are ‘correct’. Consistency is evaluated both at the
aggregate level (consistency of WMH-CIDI and SCID prevalence estimates) and at the individual level (consistency
of WMH-CIDI and SCID diagnostic classifications). Although conventional statistics (sensitivity, specificity, Cohen’s
κ) are used to describe diagnostic consistency, an argument is made for considering the area under the receiver operator
curve (AUC) to be a more useful general-purpose measure of consistency. In addition, more detailed analyses are used
to evaluate consistency on a substantive level. These analyses begin by estimating prediction equations in a clinical 
calibration subsample, with WMH-CIDI symptom-level data used to predict SCID diagnoses, and using the coeffi-
cients from these equations to assign predicted probabilities of SCID diagnoses to each respondent in the remainder of
the sample. Substantive analyses then investigate whether estimates of prevalence and associations when based on
WMH-CIDI diagnoses are consistent with those based on predicted SCID diagnoses. Multiple imputation is used to
adjust estimated standard errors for the imprecision introduced by SCID diagnoses being imputed under a model rather
than measured directly. A brief illustration of this approach is presented in comparing the precision of SCID and
predicted SCID estimates of prevalence and correlates under varying sample designs.
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Introduction
This paper discusses the rationale, design, and
analysis plan for the clinical calibration studies
carried out in conjunction with the US National
Comorbidity Survey Replication (NCS-R). Similar
procedures are being used in clinical calibrations in
two other US surveys that are being carried out in
conjunction with the NCS-R – the National Latino
and Asian American Survey (NLAAS) and the
National Survey of American Life (NSAL) – as well
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as in a number of surveys participating in the World
Health Organization’s (WHO) World Mental Health
(WMH) Survey Initiative (Kessler, 1999; Kessler and
Üstün, 2000). These studies are being conducted in
order to increase the clinical relevance of the survey
results by calibrating the American Psychiatric
Association’s (APA) Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-
IV) diagnoses from the fully structured WMH-CIDI
interviews to independent clinical diagnoses from
semi-structured research diagnostic interviews based
on the Structured Clinical Interview for DSM-IV
(SCID) (First, Spitzer, Gibbon and Williams, 2002). 
As detailed in the body of the paper, the calibra-
tion includes three phases. The first two phases
compare WMH-CIDI diagnoses with independent
clinical diagnoses. The first is an aggregate investiga-
tion of bias in prevalence estimates that includes an
initial estimation aimed at characterizing the perfor-
mance of the WMH-CIDI, followed by an evaluation
aimed at determining whether this performance
could be improved by substantively reasonable modi-
fications of the WMH-CIDI diagnostic algorithm.
The second phase is an individual-level investigation
of concordance. The third phase consists of the
development of prediction equations in the clinical
calibration subsamples in order to generate predicted
probabilities of clinical diagnoses from WMH-CIDI
data for each respondent in each of the three surveys.
As detailed in the body of the paper, these predicted
probabilities can be treated directly as outcomes in
substantive analyses or can be used as the input to
more complex analyses that use the method of
multiple imputation (MI) (Rubin, 1987) to make
estimates of the prevalence and correlates of clinical
diagnoses from WMH-CIDI data. Comparison with
parallel estimates of the prevalence and correlates of
WMH-CIDI diagnoses allows direct evaluations of
consistency that are much more meaningful than
conventional analyses of diagnostic concordance. 
The clinical relevance of prevalence estimates in
epidemiological surveys
The prevalence estimates in the Epidemiologic
Catchment Area (ECA) study (Robins and Regier,
1991) and subsequently in the National Comorbidity
Survey (NCS) (Kessler, McGonagle, Zhao, Nelson,
Hughes, Eshleman, Wittchen and Kendler, 1994)
were considerably higher than expected by most
health policy analysts. Approximately 30% of
respondents in the 18–54 age range met criteria for
one or more of the DSM-III (ECA) or DSM-III-R
(NCS) disorders assessed in those surveys in the 12
months before interview (Regier, Kaelber, Rae,
Farmer, Knauper, Kessler and Norquist, 1998).
Furthermore, this is a lower bound estimate, as
neither of the surveys included the full range of DSM
disorders in their assessments and even this range of
disorders is likely to be non-inclusive (Angold,
Costello, Farmer, Burns and Erkanli, 1999; Pincus,
Davis and McQueen, 1999).
The initial reaction to these results among health
policy analysts was one of disbelief. The most
obvious interpretation was that the lay administered
diagnostic interviews – the Diagnostic Interview
Schedule (DIS) in the ECA (Robins, Helzer,
Croughan and Ratcliff, 1981) and a modified version
of the Composite International Diagnostic Interview
(CIDI) in the NCS (Robins, Wing, Wittchen,
Helzer, Babor, Burke, Farmer, Jablenski, Pickens,
Regier et al., 1988) – were upwardly biased.
However, clinical calibration studies carried out in
conjunction with both surveys showed that the DIS
and CIDI prevalence estimates were not any higher
than those found in blind semi-structured clinical
interviews (Kessler, Wittchen, Abelson, McGonagle,
Schwarz, Kendler, Knauper and Zhao, 1998; Eaton,
Neufeld, Chen and Cai, 2000). This led critics to
conclude that the DSM system itself is overly inclu-
sive (Pincus, Zarin and First, 1998; Regier et al.,
1998; Üstün, Chatterji and Rehm, 1998). This
conclusion was instrumental in causing an APA task
force to add a clinical significance criterion to many
disorders in the DSM-IV in order to remind readers
of the basic definition of a mental disorder in the
introduction of the manual. 
The NCS-R, NLAAS, and NSAL are the first
major general population surveys in the US to
administer a modified version of the CIDI that
includes questions designed to operationalize the
DSM-IV criteria. An earlier post hoc analysis of the
ECA and NCS data attempted to produce provi-
sional DSM-IV prevalence estimates by making use
of questions in the ECA and NCS that were relevant
to the new criteria (Narrow, Rae, Robins and Regier,
2002). However, as the ECA and NCS were not
designed with DSM-IV criteria in mind, the new
criteria were not well operationalized in those
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surveys, raising doubts about the accuracy of the
provisional prevalence estimates.
Given that the WMH-CIDI, the version of the
CIDI used in the NCS-R, NLAAS, NSAL, and the
WHO World Mental Health (WMH) surveys, is a
new version of CIDI, it is important to check its
consistency with diagnoses based on clinical reinter-
views. Confirmation of consistency with clinical
diagnoses is needed before accepting the new DSM-
IV prevalence estimates as accurate. Based on this
realization, a clinical calibration phase was built
into all three US surveys as well as into WMH
surveys in a number of other countries (China,
France, India, Italy, Lebanon, Nigeria, South Africa,
Spain). The methods used in these clinical calibra-
tion studies were co-ordinated across all surveys and
countries in order to facilitate comparative analysis. 
Before turning to a discussion of these co-
ordinated methods, it should be noted that the
discussion of clinical relevance has now advanced
beyond a simple consideration of prevalence.
Specifically, in recognition of the fact that the true
population prevalence of mental disorders, when it
is finally established, will almost certainly turn out
to exceed the resources available to treat these
disorders, mental health policy advocates have
proposed several more restrictive definitions that
can be used to narrow the number of people quali-
fying for treatment. The National Institute of
Mental Health (NIMH) National Advisory Mental
Health Council, for example, distinguished people
with Severe and Persistent Mental Illness (SPMI)
from other mentally ill people (National Advisory
Mental Health Council, 1993), while the Alcohol,
Drug Abuse, and Mental Health Administration
Reorganization Act stipulated that state mental
health block grant funds can be used only to treat
people with serious mental illness (Substance Abuse
and Mental Health Services Administration, 1993).
Many health plans in the US have followed suit by
restricting mental health coverage to a subset of
DSM disorders that they consider to be ‘biologically
based’.
In terms of research, the suggestion has been
made that epidemiological surveys should go beyond
simple dichotomous diagnostic distinctions to
include additional dimensional measures of clinical
severity (Regier, 2000). As noted by Kessler and
Üstün (2004), such measures are included in the
WMH-CIDI. Fully structured versions of standard
clinical severity scales, such as the Inventory of
Depressive Symptomatology (Rush, Gullion, Basco,
Jarrett and Trivedi, 1996) and the Panic Severity
Test (Houck, Spiegel, Shear and Rucci, 2002), are
embedded in the WMH-CIDI to assess the severity
of individual disorders. The WHO Disability
Assessment Schedule (WHO-DAS) (Rehm, Üstün,
Saxena, Nelson, Chatterji, Ivis and Adlaf, 1999) is
included in the WMH-CIDI to assess the severity of
overall psychopathology. As a result, the assessment
of clinical significance in the WMH-CIDI does not
hinge entirely on concordance of the categorical
DSM-IV diagnoses generated by the WMH-CIDI
with independent clinical diagnoses. The current
paper, however, focuses on only this one aspect of
clinical significance.
The conventional clinical calibration design
There is considerable uncertainty regarding the best
design to use in validating fully structured diagnostic
interviews like the WMH-CIDI. The standard design
is the double-blind test-retest design in which a
probability subsample of respondents in a community
survey that over-samples respondents with CIDI diag-
noses is reinterviewed by trained clinical interviewers
who administer a gold standard semi-structured
research diagnostic interview such as the SCID (First
et al., 2002). The clinical interviewers are blind to
the CIDI diagnoses. Assessment of concordance
between the CIDI and clinical diagnoses is then
made by evaluating the sensitivity and specificity of
the CIDI and by calculating Cohen’s κ (Cohen,
1960) to measure overall concordance. However, as
noted by Robins (1985), this design is flawed in a
number of ways. 
First, and perhaps most obviously, the semi-
structured clinical research diagnostic interviews
that are used as the gold standard against which to
validate lay-administered interviews have their own
errors. Although psychometric data on the DSM-IV
version of the SCID have not been published, a
short-term test-retest reliability study of the DSM-
III-R version of the instrument in two non-patient
samples found quite low concordance over time, with
a mean κ of 0.37 for current diagnoses and 0.51 for
lifetime diagnoses (Williams, Gibbon, First, Spitzer,
Davies, Borus, Howes, Kane, Harrison, Rounsaville
and Wittchen, 1992). If classical test theory assump-
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tions hold (Crocker and Algina, 1986), then the
concordance between WMH-CIDI and SCID diag-
noses can be no higher than these reliabilities. The
low reliability of the SCID is more pronounced in
community than clinical samples (Williams et al.,
1992). This could be due to patients reporting more
consistently over time than community cases, to
clinical interviewers being more consistent in rating
the presumably more severe symptoms of patients
than community cases, or, depending on whether a
measure of reliability is being used that is sensitive to
prevalence, on different prevalence in clinical than
community samples. Some insight into the first two
of these possibilities can be gleaned from studies that
tape record clinical interviews and have the tapes
reviewed by a second clinical interviewer who re-
rates all the symptoms. This is the typical method
used to confirm the adequacy of the training of clin-
ical interviewers to carry out CIDI validation studies.
This exercise consistently finds very high levels of
agreement among clinical interviewers in their
ratings of a single tape (Wittchen, 1994). A
confounding factor here is that the audiotape only
includes responses to questions solicited by the first
interviewer. The second interviewer does not have
the opportunity to ask additional questions.
Nonetheless, to the extent that the second inter-
viewer feels comfortable making a diagnostic rating
based on the questions asked by the first interviewer,
the high concordance found in studies of this type
implies that the low test-retest reliability of clinical
interviews in community samples is due more to
inconsistency over time on the part of respondents
than to inconsistent ratings on the part of clinical
interviewers. 
Second, even though the low test-retest reliability
of clinical interviews is a serious problem, there is an
even greater problem in using semi-structured clin-
ical interviews as a validation standard. The formal
way of stating this problem is to say that the classical
test theory assumption of inter-temporally uncorre-
lated measurement errors is unlikely to hold for long,
emotionally draining interviews such as the CIDI or
SCID. The reason is that respondents with complex
histories of mental disorder are aware after the first
interview that they can skip out of large portions of
the reinterview simply by denying diagnostic stem
questions. Indeed, debriefing of pilot test 
respondents in conjunction with the NCS showed
that respondents with complex histories of mental
disorder usually pick up on the stem-branch logic of
the interview part way through and deny stem ques-
tions that they know they should endorse in latter
sections in a conscious effort to shorten the inter-
view (Kessler, Wittchen, Abelson and Zhao, 2000).
This means that estimates of test-retest reliability
will be biased. Furthermore, it means that second
interviews will underestimate disorder prevalence
significantly. Bromet et al. (1986) clearly demon-
strated this last finding in a community survey that
interviewed 391 women twice over an 18-month
time interval with a semi-structured clinical research
diagnostic interview that was a predecessor to the
SCID. Test-retest reliability was poor and the preva-
lence estimate was significantly lower in the second
than the first wave of data collection.
Third, moving beyond the issue of reliability to
the deeper issue of validity, questions can be raised
about the validity of semi-structured clinical inter-
views in operationalizing DSM criteria. The problem
is that many DSM criteria are not sufficiently precise
to be operationalized unequivocally even with
exhaustive clinical assessments. For example, crite-
rion A.1.(e) in the DSM-IV diagnosis of
Attention-Deficit/Hyperactivity Disorder is that the
patient ‘often has difficulty organizing tasks and
activities’. But how often is ‘often’? What kinds and
severities of organizational problems constitute 
‘difficulty’? Answers to these questions need to be
more clearly specified in order to allow clinical inter-
viewers to make accurate assessments. As the DSM
system provides little guidance in this regard, the
developers of semi-structured clinical interviews
have created their own operational standards.
Although this is done to improve consistency of clin-
ical rating (reliability), it also has the potential to
reduce validity to the extent that the developers of
these interviews have different ideas than the devel-
opers of the DSM about operational characteristics.
To the extent that discrepancies between CIDI and
SCID diagnoses are due to operational decisions that
go beyond the DSM (for example, the decision 
that the word ‘often’ means ‘at least several times a
week’ or the decision that the word ‘difficulty’ means
‘serious enough to be noticed as a problem by a
teacher or a work supervisor’), the discrepancies
have to be seen as due to lack of validity in the DSM
system rather than in the WMH-CIDI. 
Clinical calibration of DSM-IV diagnoses in the WMH-CIDI
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Fourth, questions have been raised about the stan-
dard interpretation of the statistics most often used
to describe concordance between CIDI diagnoses
and blind clinical diagnoses. Cohen’s κ is the main
source of controversy (Byrt, Bishop and Carlin, 1993;
Cook, 1998; Kraemer, Morgan, Leech, Gliner, Vaske
and Harmon, 2003), as κ is dependent on prevalence
and κ consequently is often low in situations where
there appears to be high agreement between low-
prevalence measures (Feinstein and Cicchetti,
1990). Furthermore, κ varies across populations that
differ in prevalence even when the populations do
not differ in sensitivity (the percentage of true cases
correctly classified by the CIDI) or specificity (the
percent of true non-cases correctly classified). As
sensitivity and specificity are considered by many
substantive researchers to be fundamental parame-
ters, this means that the comparison of κ across
different populations cannot be used to evaluate the
cross-population performance of a test. 
Alternatives to the conventional design
A number of approaches have been proposed to go
beyond the conventional clinical calibration design
in ways that address one or more of the problems
described in the last section. None of them is perfect,
but it is nonetheless useful to consider them here.
The most simple of these approaches is to correct
estimates of concordance based on the assumption
that semi-structured clinical interviews are merely
unreliable, but not invalid, and that measurement
error is random. If this assumption is made, simple
psychometric methods based on latent class models
can be used both to correct estimates of overall
concordance between CIDI diagnoses and clinical
diagnoses and to estimate true prevalence (Garrett,
Eaton and Zeger, 2002). However, the models on
which these methods are based require the researcher
to make identifying assumptions that are likely to be
implausible for reasons described in the previous
section of this paper (Faraone and Tsuang, 1994). 
Another approach is to collect additional data to
improve the accuracy of clinical assessments in order
to generate diagnoses that might reasonably be taken
as both reliable and valid. This is sometimes done by
carrying out a second clinical interview aimed at
reconciling discrepancies between diagnoses in the
CIDI and in the initial clinical interview (Mannuzza,
Fyer, Martin, Gallops, Endicott, Gorman, Liebowitz
and Klein, 1989; Williams et al., 1992). It is also
possible to augment the information collected in
such reconciliation interviews with medical records,
informant reports, and reviews of all available infor-
mation by independent expert clinicians in order to
arrive at the most accurate possible clinical classifi-
cation (Fennig, Craig, Lavelle, Kovasznay and
Bromet, 1994; Ramirez Basco, Bostic, Davies, Rush,
Witte, Hendrickse and Barnett, 2000). The difficulty
with this approach is the one mentioned in the last
section in conjunction with the research of Bromet
et al. (1986) – that community respondents tend to
report less and less as we interview them more and
more, leading to the biased perception that initial
structured interviews overestimate prevalence
compared to second clinical interviews. Added to
this is the consistent finding that respondents in
reconciliation interviews usually resolve discrepan-
cies in favour of their most recent interview. Both of
these findings argue against the likelihood of more
extensive data collection efforts resulting in totally
unbiased clinical classifications.
An interesting alternative approach is what might
be called the mixed single-interview design. In this
approach the researcher investigates the extent to
which diagnostic decisions in a single interview
differ depending on whether the information is
obtained entirely from structured responses to CIDI
questions or from open-ended responses to semi-
structured clinical questions. Janca et al. (1992)
carried out a study of this sort with an early version
of the CIDI. Clinical interviewers either adminis-
tered a CIDI or sat in the room with a lay interviewer
who was administering a CIDI. The clinical inter-
viewers filled out a DSM-III-R clinical checklist
simultaneously with the CIDI administration. They
could ask additional semi-structured questions when-
ever the CIDI response provided insufficient
information to code the relevant symptom on the
clinical checklist. Analysis consisted of comparing
diagnoses based entirely on CIDI responses with
those based on responses to the clinical checklist.
Diagnostic concordance was quite good, averaging κ
= 0.78 across diagnoses, with no systematic differ-
ence in prevalence estimates between diagnoses
based on the CIDI versus on the clinical checklist.
This result is consistent with the interpretation that
the much greater discrepancy between CIDI 
diagnoses and clinical diagnoses, when the latter are
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based on a second interview rsther than on a mixed
single-interview, are due to community respondents
becoming more reluctant to admit disorders in
second interviews. 
The ideal design to confirm this interpretation
would be one in which random half-samples of
respondents were assigned either to mixed single-
interview or test-retest interview assessments. We
are not aware of any study that has used this design.
Nonetheless, the mixed single-interview approach is
very useful even without this additional design
element in shifting the underlying research question
in a way that finesses the problem of not having a
gold standard. In the conventional clinical calibra-
tion design, the research question is ‘How valid is the
CIDI?’ In order to answer this question, the
researcher is required to create a perfectly reliable
and valid gold standard either explicitly (by carrying
out a clinical assessment that he is willing to accept
as perfectly reliable and valid) or implicitly (by using
psychometric methods to estimate a latent variable
model, which is assumed to create an unbiased repre-
sentation of the disorder). In the mixed
single-interview design, in comparison, the research
question changes to: ‘What difference does it make
to survey results that lay interviewers administered
fully-structured diagnostic interviews rather than
clinical interviewers administered semi-structured
diagnostic interviews?’ This is a more modest ques-
tion, of course, than the question asked in the
conventional design. It is a more practical question
too, as clinical decisions are made on the basis of
clinical assessments that are not always perfectly reli-
able and valid. Furthermore, it is an answerable
question, unlike the question asked in the conven-
tional design, because it can be answered without
having to create a perfectly reliable and valid gold
standard.
A design that is indirectly related to the mixed
single-interview design is the predictive validity
design. In this approach, baseline diagnoses from
CIDI interviews and clinical reinterviews are
compared in relative predictive power for relevant
outcome variables (for example, psychiatric hospital-
ization, onset of work disability for emotional
problems, suicide attempt). As in the mixed single-
interview design, the implicit question is: ‘What
difference does it make that diagnoses are based on
fully structured versus semi-structured diagnostic
interviews?’ In this case, though, the question
concerns the difference it makes to conclusions
about effects of the disorders rather than about
prevalence of the disorders. The limited amount of
methodological research that has been carried out
using the predictive validity design suggests that the
associations of fully structured interviews with a
range of clinical outcomes are nearly as strong as the
associations of clinician assessments with the same
outcomes (Helzer, Spitznagel and McEvoy, 1987;
Robins, 1989). Unlike the mixed single-interview
design, the predictive validity design can also be used
to make some inferences about comparative relia-
bility. Specifically, the relative predictive power of
two types of diagnoses can be assumed equivalent to
the relative strength of association between true
unmeasured disorder and the two types of diagnoses
if (1) true unmeasured disorder is the only systematic
determinant of diagnoses in both types of diagnoses
and (2) the effects of these diagnoses on the
outcomes are totally due to their links with true
unmeasured disorders. Needless to say, though, the
plausibility of these assumptions can be called into
question. 
Alternative measures of concordance
As noted above, the fact that κ varies with preva-
lence even when sensitivity (SENS) and specificity
(SPEC) are constant has been a concern to critics.
These critics prefer to assess overall strength of asso-
ciation with measures that are a function of SENS
and SPEC. The odds-ratio (OR) meets this require-
ment, as OR = [SENS × SPEC]/[(1 − SENS) × (1 –
SPEC)] (Agresti, 1996). However, the upper end of
OR is unbounded, making it difficult to use OR to
evaluate the extent to which CIDI diagnoses are
consistent with clinical diagnoses. Yules Q has been
proposed as an alternative measure to resolve this
problem (Spitznagel and Helzer, 1985), as Q is a
bounded transformation of OR [Q = (OR − 1)/(OR +
1)] that ranges between –1 and +1. Q can be inter-
preted as the difference in the probabilities of a
randomly selected clinical case and a randomly
selected clinical non-case that differ in their classifi-
cation on the CIDI being correctly versus incorrectly
classified by the CIDI. The difficulty with Q is that
‘tied pairs’ (clinical cases and non-cases that have
the same CIDI classification) are excluded. This
means that Q does not tell us about actual prediction
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accuracy. The area under the receiver operator char-
acteristic curve (AUC) is a measure that resolves this
problem. Although developed for quite a different
purpose – to study the association between a contin-
uous predictor and a dichotomous outcome – the
AUC can also be used in the special case where 
the predictor is a dichotomy. In this special case,
AUC is equal to (SENS + SPEC)/2. The AUC can
be interpreted as the probability that a randomly
selected clinical case will score higher on the CIDI
than a randomly selected non-case (Hanley and
McNeil, 1982). As a result of this useful interpreta-
tion, we focus on AUC in our evaluation of
diagnostic concordance between the WMH-CIDI
and the SCID. 
The WMH-CIDI clinical calibration design
Based on our evaluation of the alternatives to the
conventional design reviewed in the last section, we
were attracted to the mixed single-interview design
as we planned the WMH-CIDI clinical calibration
studies. However, further consideration showed that
this design has four practical implementation prob-
lems in the context of a major community
epidemiological survey that made us reject it as the
design for the WMH-CIDI clinical calibration
studies. First, as the clinical interviewer administers
both the CIDI and the clinical interview together in
the mixed single-interview design, the blindness that
exists in the conventional design is broken and
opportunities arise for bias in evaluation. It is
possible to reduce this problem considerably by
requiring the clinical interview to probe aggressively,
but this then creates a second problem: that the
interview becomes a good deal longer and much
more conversational than the standard CIDI,
possibly leading to changes in the response style of
respondents due to differences in rapport and burden.
A third problem is that full implementation of the
mixed single-interview design would require a
random subsample of survey respondents to be inter-
viewed by clinical interviewers. There are daunting
logistical and financial barriers to this in large-scale
community epidemiological surveys, especially when
the surveys are nationally representative. Fourth, the
mixed single-interview design does not include any
test of the possibility that the lay interviewers who
administer the CIDI are performing less than 
optimally either in their use of the complex probes
and feedback rules required for accurate administra-
tion of the interview or in their accuracy of data
entry. In light of these four problems, we decided
against the mixed single-interview design in evalu-
ating the WMH-CIDI. 
Despite this decision, we came away from our
review of the conventional design and its alterna-
tives with two conclusions: (1) that we would not be
able to create a gold standard measure we could plau-
sibly consider completely reliable and valid in a
conventional double-blind test-retest design; and (2)
that because of this first conclusion we should focus
on the kinds of methodological questions that are
addressed in the mixed single-interview and predic-
tive validity designs. We wanted to do this, though,
without actually using the mixed single-interview
design. We decided to do this by using a modified
version of the double-blind test-retest design based
on an observation made in our earlier methodolog-
ical studies of the CIDI in the NCS (Kessler et al.,
1998), which was subsequently confirmed in a
different context by other investigators (Lucas,
Fisher, Piacentini, Zhang, Jensen, Shaffer, Dulcan,
Schwab-Stone, Regier and Canino, 1999): that the
drop-off in diagnostic reports in clinical reinterviews
compared to initial fully structured diagnostic inter-
views is concentrated largely in diagnostic stem
questions. This means that a method that reduces
the underreporting of diagnostic stem questions in
clinical reinterviews would resolve a large part of the
drop-off problem. The resolution of this problem, in
conjunction with a short enough time interval in a
test-retest that clinical status could be assumed to
remain unchanged, would make it possible to address
the question in the mixed single-interview design:
‘What difference does it make to survey results that
we use lay interviewers to administer fully-structured
diagnostic interviews rather than clinical inter-
viewers to administer semi-structured diagnostic
interviews?’ 
The modified double-blind test-retest method
made two changes to clinical reinterviews. First, we
unblinded the interviewers to whether the respon-
dents endorsed diagnostic stem questions in the
WMH-CIDI, but not to the final WMH-CIDI diag-
noses. Second, we ‘forced’ respondents to endorse
these stem questions in the clinical reinterviews.
The partial unblinding of interviewers might be seen
as introducing a bias, but it turns out that this is not
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the case due to the fact that the majority of 
community survey respondents who endorse WMH-
CIDI stem questions do not go on to meet full
WMH-CIDI criteria for the associated disorder. The
‘forcing’ of stem question endorsement, in compar-
ison, has a substantial effect on the completeness of
respondent reports in clinical reinterviews. This is
achieved by telling respondents at the beginning of
their clinical reinterview that they will be asked
some of the same questions as in their earlier inter-
view. They are also told that this is being done to test
the interview and not to test their memory, so they
should answer without trying to remember what 
they said to the earlier interviewer. They are then
taken through the clinical interview in the usual
fashion, with the exception that the sections of the
clinical reinterview in which they endorsed a diag-
nostic stem question in the WMH-CIDI are started
with the introduction: ‘During the first interview,
you said [presentation of the stem question endorsed
in the NCS interview]. Has that happened in the
past 12 months?’ This introduction is substituted for
the conventional stem-branch structure of the
sections, in which diagnostic stem questions are
asked and subsequent branch questions are asked
only if the respondent endorses the stem questions.
As is typical in clinical interviews, our clinical inter-
viewers also have great flexibility in going back to a
diagnostic section that was previously skipped if any
information subsequently surfaces in the interview to
suggest a positive response to the diagnostic stem
question. Reinterview respondents can still deny
that they reported a diagnostic stem question in the
initial interview, but this is uncommon. We also
rotate the order of administration of sections in the
clinical interview to see if the order bias found in
previous methodological studies of research diag-
nostic interviews (Jensen, Watanabe and Richters,
1999) can still be observed when we use this stem-
forcing approach. 
Clinical instrumentation, training and supervision
As noted in the introduction, the clinical interview
used in the WMH-CIDI clinical calibration studies is
the SCID (First et al., 2002). The version of the
SCID used is a modified version of the 12-month
Axis I research version, non-patient edition. An
expanded version of the model programme created
by the developers of the SCID (Gibbon, McDonald-
Scott and Endicott, 1981) was used for interviewer
training. The lifetime version is also used in the
NCS-R. This programme featured the following
three phases: (1) the use of the standard SCID
training tapes and manuals, which take an average of
approximately 30 hours of self-study; (2) 40 hours of
in-person group training by experienced SCID
trainers; and (3) ongoing quality-control monitoring
throughout the field period. Quality control moni-
toring included clinical supervisor (JA, MG, FE)
review of all hard copy completed SCID interviews,
re-contact of respondents whenever the clinical
supervisor felt that more information was needed to
make a rating, periodic consultation with diagnostic
experts who served as consultants for complex cases
(JE, MG, MH, PW), consultant review of a random
subsample of interview audiotapes, and biweekly
interviewer-supervisor meetings to prevent drift.
The first of the three training phases was constant
across all the countries that participated in the
WMH-CIDI clinical calibration study. However,
training materials were all in English, which meant
that clinical interviewers in non-English speaking
countries had to be bilingual and were trained in
what was to them a foreign language. Because of this,
special care was taken to expand the second phase of
training in countries other than the US and to have
the clinical supervisors in these studies specially
trained by the US trainers (MH, MG). In addition,
the US trainers provided an ongoing telephone 
and e-mail consultation service to clinical supervi-
sors in these other countries throughout the field
period in conjunction with their quality control
monitoring.
In the US studies, the SCID interviews were
administered by telephone and were audiotaped for
future methodological study after obtaining permis-
sion from respondents. Telephone administration of
SCID interviews is now widely accepted based on
evidence of comparable validity to in-person admin-
istration (Kendler, Neale, Kessler, Heath and Eaves,
1992; Sobin, Weissman, Goldstein, Adams,
Wickramaratne, Warner and Lish, 1993; Rohde and
Seeley, 1997). A great advantage of telephone
administration is that a centralized and closely super-
vised clinical interview staff can carry out the
interviews throughout the country. A disadvantage is
that the roughly 5% of people in the household
population of the US without telephones cannot be
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included in clinical calibration studies when inter-
views are done by telephone. We were willing to
make this trade-off in the US because the proportion
of respondents without a telephone was small. In
countries with lower telephone penetration, though,
the WMH researchers usually decided to carry out
SCID reinterviews in person rather than by tele-
phone in order to avoid sample bias. In these
countries, the SCID subsamples were concentrated
in selected cities or regions of the country in order to
avoid the logistical complications of administering
in-person clinical reinterviews throughout the
country. 
Sampling
The 12-month clinical calibration subsamples over-
sampled 12-month WMH-CIDI cases, but also
included non-cases, while the lifetime clinical cali-
bration subsample (carried out only in the NCS-R)
oversampled lifetime WMH-CIDI cases. The exact
methods of subsampling differed across surveys, but
in each case disproportionate sampling was based on
probability procedures so that the clinical calibration
subsample could be weighted back to be representa-
tive of the total original sample. This reweighting
took into consideration the sample design of the
original surveys, including differential probability of
selection in households depending on sample size
and post-stratification. The clinical subsample sizes
in the US surveys for 12-month clinical reappraisal
were 360 in the NCS-R, 195 in the NLAAS, and 677
in the NSAL. Each of these clinical reappraisal
studies evaluated DSM-IV Major Depressive
Episode, Dysthymia, Generalized Anxiety Disorder,
Panic Disorder, Phobia, Post-Traumatic Stress
Disorder, Alcohol Abuse-Dependence, and Drug
Abuse-Dependence. In addition, a separate lifetime
clinical reappraisal study of the same diagnoses was
carried out in the NCS-R (n = 328). The NCS-R
also included separate clinical reappraisal studies of
non-affective psychosis (n = 73) and adult attention-
deficit/hyperactivity disorder (n = 154) as well as an
ongoing study of bipolar spectrum disorder. 
Investigating aggregate concordance
After weighting the data to be representative of the
entire sample, the first question investigated in
analysis of the clinical calibration data is whether
the WMH-CIDI prevalence estimates are compa-
rable to the SCID prevalence estimates. The
McNemar test is used here to compare the signifi-
cance of the difference between the number of +–
and –+ cases in the 2 × 2 cross-classification of
WMH-CIDI and SCID diagnoses. As with all signifi-
cance tests in the clinical calibration subsamples, the
McNemar tests are carried out using design-based
estimation methods that adjust for the effects of
weighting and clustering of the initial survey data as
well as for the over-sampling of WMH-CIDI cases
(Kish and Frankel, 1974; Wolter, 1985). Our
previous work in the NCS, which used the same
design, found that CIDI-SCID differences in DSM-
III-R prevalence estimates were not statistically
significant for the vast majority of the disorders
assessed in the survey (Kessler et al., 1998). We do
not yet know, though, whether the same result will
hold for the DSM-IV diagnoses in the WMH-CIDI.
As noted in the introduction, disaggregated analyses
aimed at pinpointing symptoms responsible for diag-
nostic discrepancies are being carried out in cases
where WMH-CIDI prevalence estimates differ signif-
icantly from SCID prevalence estimates. As the
main difference between DSM-III-R and DSM-IV
diagnostic criteria for most disorders is the inclusion
of a new clinical significance criterion, we are espe-
cially interested in investigating the extent to which
CIDI-SCID prevalence differences can be reduced by
modifying the thresholds on the WMH-CIDI scales
of clinically significant distress or impairment. If
comparable WMH-CIDI modifications across disor-
ders are found to reduce CIDI-SCID diagnostic
discrepancies, these modifications will be imple-
mented in the WMH-CIDI diagnostic algorithms. 
Investigating individual-level concordance
Individual-level diagnostic concordance between the
WMH-CIDI and the SCID is being evaluated with 
2 × 2 cross-classifications of diagnoses based on the
two interviews. Overall statistical significance is
evaluated with design-based χ2 tests. We do not
aspire to estimate validity due to our belief, discussed
in earlier sections of the paper, that the SCID does
not represent a totally reliable and valid gold stan-
dard. Our main concern, instead, is with the extent
to which WMH-CIDI diagnoses reproduce SCID
aggregate prevalence estimates and individual-level
diagnostic classifications. As a result, a number of
descriptive measures of overall concordance are
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being computed. As noted above, our preferred
measure of overall classification accuracy is the
AUC. However, we also compute Cohen’s κ, OR,
and Q for purposes of comparison to other studies.
We take into consideration the fact that the upper
bound of AUC is less than 1.0 because the SCID
diagnoses are not perfectly reliable. More disaggre-
gated descriptive measures are also computed from
the perspective of the SCID as the gold standard,
including sensitivity (the proportion of SCID cases
who are detected in the WMH-CIDI), sensitivity
(the proportion of SCID non-cases who are classified
as non-cases in the WMH-CIDI), positive predictive
value (PPV) the proportion of WMH-CIDI cases
who are confirmed by the SCID), and negative
predictive value (NPV) (the proportion of WMH-
CIDI non-cases that are confirmed as non-cases by
the SCID).
Calibration of WMH-CIDI data to SCID 
diagnoses
We are also estimating logistic regression equations
in which SCID diagnoses are treated as dichotomous
outcomes and WMH-CIDI symptom variables (not
merely dichotomous WMH-CIDI diagnoses) are
predictors. The goal is to see if WMH-CIDI
symptom-level data can significantly improve the
prediction of SCID diagnoses compared to an equa-
tion in which dichotomous WMH-CIDI diagnoses
are the only predictors. Note that these predicted
probabilities are extensions of the measures of PPV
used in standard 2 × 2 tables of diagnostic concor-
dance. The AUC is the descriptive statistic used to
evaluate these improvements. As noted earlier in
this paper, the AUC is typically used with a dimen-
sional predictor and a dichotomous outcome. As a
result, it is a simple matter to think of the AUC as
the association between a predicted probability of a
dichotomous outcome, in our case based on a logistic
regression equation, and the observed classifications
on the outcome. This makes it possible to evaluate
the extent to which AUC increases as more complex
predictors are added to an equation over and above
an initial dichotomous predictor (the WMH-CIDI
dichotomous diagnostic classification). 
Results from the NCS-R clinical calibration study
show consistently that AUC increases significantly
when WMH-CIDI symptom data are added to equa-
tions that include dichotomous WMH-CIDI
diagnostic classifications. For example, concordance
(AUC) between WMH-CIDI and SCID diagnoses of
lifetime major depressive episode (MDE) in the
NCS-R clinical calibration subsample increases from
0.77 to 0.86 when WMH-CIDI depression symptom
measures are added as predictors to an equation that
includes the dichotomous WMH-CIDI MDE diag-
nostic classification as the only predictor. This
finding documents that the WMH-CIDI diagnostic
algorithm is statistically suboptimal in using all the
data in the WMH-CIDI to classify SCID cases.
Once these equations are estimated, the coeffi-
cients are used to impute predicted probabilities of
SCID diagnoses for each survey respondent who 
is not in the clinical calibration subsample. This is
actually done 10 different times by generating that
number of pseudo replications of the clinical
subsample. The reason for generating 10 separate
estimates will be discussed shortly. For now, though,
it is sufficient to note that a prevalence estimate of
each SCID diagnosis in the total sample can be
generated from these predicted probabilities. These
prevalence estimates were unbiased so long as the
clinical calibration subsample was weighted to adjust
for the over-sampling of WMH-CIDI cases before
estimating the imputation equations and so long as
the imputation equations were saturated. 
The standard error (SE) of these prevalence esti-
mates can be obtained using conventional methods
of double sampling (Shrout and Newman, 1989).
This approach could be extended to the investiga-
tion of correlates of SCID disorders by calculating
estimates of SCID prevalence and SEs in subgroups.
However, such data could not be obtained for every
subgroup of interest because of limitations in the size
of the clinical calibration subsample. An alternative
is to expand the initial imputation prediction equa-
tions to investigate whether coefficients are similar
in subgroups (for example, whether WMH-CIDI
symptom questions interact significantly with
subgroup measures such as age or sex to predict SCID
diagnoses). If no differences are found, or if such
differences are built into the prediction equations,
then significant differences in the predicted proba-
bilities imply differences in the same direction in the
SCID prevalence (although the predicted probabili-
ties do not necessarily translate directly into
estimates of the magnitude of the SCID prevalence
differences). 
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This approach of expanding the imputation equa-
tions to adjust for all possible subgroup differences in
interactions with WMH-CIDI measures will almost
certainly be imperfect, especially because of the usual
model specification strategy of excluding (setting to
zero) model coefficients that cannot be estimated
with adequate power from the data in the clinical
calibration subsample. As a result, some bias will
exist in using the predicted probabilities for subgroup
comparisons of SCID prevalence. However, the
greater the predictive power of the WMH-CIDI
questions, the less the predicted probabilities will
rely on the model and the less danger there will be
that bias will affect important results. Furthermore,
the assumption that non-significant or non-
estimable coefficients are zero is often a scientifically
plausible basis for making comparisons among
subgroups and is quite efficient relative to an
approach that requires estimating separate prediction
models in each subgroup.
Several methods exist to analyse the correlates of
SCID predicted probabilities. One is to treat the
mean predicted probability as the variable of interest
in linear or restricted linear (for example, Tobit)
prediction equations. Another possibility, which is
useful when a single SCID diagnosis is the focus of
attention, is to reproduce the observational record
for each respondent so that the sample is treated as
having two times as many observations as it actually
has. The pair of records for each respondent is then
coded so that one is defined as having the SCID
diagnosis and the other as not. The weights for these
two records are then defined as the original sample
weight multiplied by (ps) for the SCID-positive
record and (1 – ps) for the SCID-negative record,
where ps is the mean predicted probability of the
SCID diagnosis from the respondent’s imputation
equations. If the research question deals with comor-
bidity among a number of SCID diagnoses, though,
this approach becomes quite cumbersome, as it
requires assigning a weight to every possible combi-
nation of positive and negative diagnoses, thereby
vastly expanding the dataset and rendering the vari-
ance estimation more problematical. 
A more parsimonious alternative is to assign each
respondent either to have or not have a given SCID
diagnosis by using a random number generator from a
binomial distribution that is defined by his mean
predicted probability from the imputation equations.
Multiple diagnoses can be imputed in the same way
from the joint probability distribution. This
approach generates unbiased and realistic representa-
tions of the predictions, although it also incorporates
some noise due to the randomness of the imputa-
tions. This sort of single stochastic imputation can
be very useful in allowing comparison of diverse
survey results based on the use of either WMH-CIDI
diagnoses or predicted SCID diagnoses. For example,
along the same lines as the predictive validity studies
mentioned earlier, we could investigate what differ-
ence it makes to use CIDI diagnoses rather than
predicted SCID diagnoses as predictors in an equa-
tion aimed at evaluating the effects of mental
disorders on role functioning. Alternatively, we
could include both WMH-CIDI and predicted SCID
diagnoses in the same prediction equation and
formally evaluate their comparative effects in
predicting role impairment (Murphy, Monson, Laird,
Sobol and Leighton, 2000; Daskalakis, Laird and
Murphy, 2002). It is also possible to create difference
scores so that we include both measures of CI and (SI
– CI) as predictors in the same equation, where CI is
a dichotomous (0,1) of whether respondent i carries
a particular WMH-CIDI diagnosis and SI is a contin-
uous measure (0 – 1) of the predicted probability of a
SCID diagnosis for respondent i. This means that (Si
– Ci) is a continuous difference score ranging
between –1 and 1 that defines the extent to which
information about the respondent’s predicted SCID
diagnosis is not captured in his WMH-CIDI diag-
nosis. It is also possible to use (Si – Ci) as an outcome
variable to investigate whether there are any system-
atic determinants of differences in WMH-CIDI and
predicted SCID diagnoses.
All the estimation methods described in the last
three paragraphs are subject to the criticism that
they do not readily facilitate proper estimation of 
the uncertainty of inference from the imputed data,
as conventional analyses treat the imputed data as
known rather than predicted from a model. The
method of multiple imputation (MI) (Rubin, 1987)
is designed to overcome this limitation by making
use of the within-person variation in imputed values
from the 10 separate imputations generated for each
respondent for each SCID diagnosis. Specifically, MI
combines information on between-person variance
in mean imputations with information on within-
person variance in individual imputations to
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calculate SEs that account for the fact that the impu-
tations are predicted rather than known. The
operational implication is that we have to estimate
each equation 10 separate times whenever we use
MI. An MI aggregation method is then used to
compute the best estimate of each coefficient by
combining information about the mean of the coeffi-
cient across the 10 imputations with information
about the standard deviation of the coefficient esti-
mates across the replications.
In the extreme case where the WMH-CIDI is
totally unrelated to a particular SCID diagnosis
(AUC = 0.5), the only systematic information in the
multiply imputed dataset will be the consistent 0.0
and 1.0 values in the subsample of respondents who
were in the clinical calibration subsample. The
expected value of predicted disorder prevalence for
each respondent who was not in the clinical calibra-
tion subsample will be the SCID prevalence in the
clinical calibration subsample. In a case of this sort,
the MI predicted SCID prevalence estimate will be
unbiased and the SE of the estimate will be equiva-
lent to the design-based SE in the clinical calibration
sub-sample. At the other extreme, where the WMH-
CIDI perfectly predicts a particular SCID diagnosis
(AUC = 1.0), the MI SE of the estimated SCID
prevalence estimate will be equivalent to the design-
based SE in the total sample. In more realistic cases
in which AUC lies between 0.5 and 1.0, the MI SE
will take into consideration both the size of the clin-
ical calibration subsample and the strength of the
association between the WMH-CIDI and the SCID.
The situation is similar for higher-order statistics,
with the exception that measures of association will
be biased towards zero by lack of concordance
between predicted and true SCID diagnoses. 
An illustration: multiple imputation of SCID
MDE in the NCS-R
An informative way to evaluate the MI approach is
to compare the SEs of estimated SCID diagnoses to
the expected SEs of diagnoses based on a hypothet-
ical SCID survey. Differences in prevalence are not
at issue here as we assume that the MI approach
produces largely unbiased estimates. The issue,
rather, is the precision with which prevalence is esti-
mated in a CIDI survey with a SCID clinical
calibration component that uses MI to impute
predicted SCID diagnoses compared to a hypothet-
ical survey that abandons the WMH-CIDI altogether
and administers the SCID to all respondents. In
carrying out this simulation we have to adjust for the
fact that a widely dispersed nationally representative
SCID survey would be much more expensive than a
WMH-CIDI survey of the same size. Included here
would be higher costs of hiring (needing to advertise
for, screen, and hire a national clinical interview
staff rather than use the existing lay interview staff of
the Survey Research Center at the University of
Michigan that carried out the US surveys), training
(at least 2 weeks of clinical interviewer training
compared to 1 week of lay interviewer training),
salary (NCS-R clinical interviewers are paid
$50/hour plus fringe benefits compared to an average
of $13/hour with no fringe benefits for lay inter-
viewers), supervision (both more intensive
supervision of clinical than lay interviewers and
much higher salaries of clinical supervisors than lay
supervisors), and post-processing (laptop computer
direct data entry of structured responses to lay inter-
views versus clinical supervisor review, coding, and
key-punching of open-ended responses to clinical
interviews). This means that, at a fixed cost, a
WMH-CIDI survey would have a considerably larger
sample size than a SCID survey. For purposes of the
following simulation, we assumed that we could carry
out a nationally representative SCID survey of
approximately 3,000 cases for the same overall cost
as a WMH-CIDI survey of approximately 10,000
cases (roughly the size of the NCS-R). 
Size of SE in the MI approach depends on six vari-
ables: true prevalence, strength of association
between the WMH-CIDI and SCID, the extent to
which true cases are over-sampled in the clinical
calibration subsample, the size of the total sample,
the size of the clinical calibration subsample, and
whether the parameter of interest is estimated in the
total sample or in subsamples. We fixed the first two
of these six variables in our simulation by focusing on
the MI SCID lifetime prevalence estimation of MDE
and assuming the actual lifetime prevalence (24.2%)
and the actual strength of association (AUC = 0.86)
found in the NCS-R (Kessler, Berglund, Demler, Jin,
Koretz, Merikangas, Rush, Walters and Wang, 2003).
We also fixed the proportional representation of true
cases in the clinical calibration subsample to be
twice as high as in the total sample. We yoked the
next two variables by assuming that we could either
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have a sample of 10,000 WMH-CIDI interviews in
which 300 respondents were reinterviewed with the
SCID (roughly equivalent to the actual NCS-R
design) or successively smaller WMH-CIDI samples
in increments of 1,000 cases in which the cost saving
of decreasing the number of WMH-CIDI interviews
was accompanied by an increase in the number of
SCID reinterviews in the ratio 1:2 (for example,
10,000 WMH-CIDI plus 300 SCID, 9,000 WMH-
CIDI plus 800 SCID, 8,000 WMH-CIDI plus 1,300
SCID, 7,000 WMH-CIDI plus 1,800 SCID). The 1:2
ratio is higher than the assumed ratio for total costs
of a WMH-CIDI survey compared to a SCID survey
because we assumed that the marginal cost of
carrying out a SCID interview over the telephone
after a WMH-CIDI interview is already done is lower
than the marginal cost of an additional face-to-face
SCID interview in the absence of an earlier WMH-
CIDI interview. Finally, we varied the estimation to
be carried out in the total sample or in subsamples of
between 2% and 90% of the total sample.
The inclusion of subsamples in the simulation is
critical because complex substantive analyses almost
always work with subsamples. Even something as
simple as examining sex differences in prevalence
requires separate estimation among men and women,
while studies of race-ethnic differences sometimes
require comparisons in subsamples that are as small
as 2% to 10% of the sample. The simulation uses the
estimates of PPV in the total sample to generate
predicted probabilities in subsamples; that is, it
assumes that PPV and NPV are constant across
subsamples. This assumption will be incorrect when
SENS and SPEC are constant and prevalence differs.
As a result of this problem, we looked for interactions
between predicted probabilities and important
subsampling variables (for example, age, sex, educa-
tion, race-ethnicity) in expansions of the basic
prediction equation before carrying out the simula-
tion. When interactions were statistically significant,
they were built into the final prediction equations to
modify the assumptions of constant PPV and NPV in
a way that reflected the actual structure in the data.
These specifications were constrained by the limited
statistical power to detect meaningful interactions in
the clinical reappraisal subsample but were nonethe-
less useful in moving beyond the assumption of
completely constant PPV and NPV.
Before turning to the substantive results, one
seemingly odd implication of the assumption
regarding the relative costs of WMH-CIDI and SCID
interviews is worthy of comment: the fact that the
smallest of the hypothetical WMH-CIDI samples
(7,000 with 1,800 SCID reinterviews) has only 1,200
fewer SCID reinterviews than the SCID-only
sample. The reader might be puzzled that we would
think these two designs are comparable in cost.
Could it possibly be the case that a reduction in
1,200 SCID interviews from the SCID-only design
could pay for 7,000 WMH-CIDI interviews? That
seems implausible on the face of it. The answer is
that we are assuming that the SCID interviews in the
hypothetical WMH-CIDI sample designs would be
carried out by telephone (an investment of only
about 3 interviewer hours per completed interview)
after the WMH-CIDI interviewer has already
recruited the household and carried out the face-to-
face WMH-CIDI interview (an investment of close
to 12 interviewer hours). In the SCID-only sample,
in comparison, the interviews would be carried out
face-to-face. This means that the SCID interviewers
would have to travel to the homes of respondents
rather than working over the telephone from a
centralized location. We assumed that the average
number of interviewer hours per completed face-to-
face interview would be higher in the SCID-only
design than the WMH-CIDI designs because it
would be more difficult to find competent clinical
interviewers than lay interviewers in all the many
different parts of the country where the NCS-R was
carried out (over 170 counties in 34 different states).
When competent interviewers cannot be found in a
sample area, we have to fly interviewers from other
areas of the country into the sample area to complete
the interviews, substantially raising the number of
hours the interviewers have to be paid per completed
interview.
With these design considerations as a background,
results of the simulation for estimating the lifetime
prevalence of SCID MDE are presented in Figure 1.
Each of the five curves in the figure represents a
different hypothetical sample design. Four of the five
are WMH-CIDI samples that range in size between
7,000 and 10,000, with the number of SCID reinter-
views varying from a low of 300 in the WMH-CIDI
10,000 sample design to a high of 1,800 in the
WMH-CIDI 7,000 sample design. The fifth is the
SCID-only sample. The x-axis of the figure repre-
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sents the proportion of the sample in which preva-
lence is being estimated, whereas the y-axis
represents the size of the SE of the prevalence esti-
mate. Two broad patterns in the figure are
noteworthy. First, the SE, as one would expect,
increases as the proportion of the sample in which
prevalence is being estimated decreases. Second, this
increase has a different functional form in the
WMH-CIDI samples than in the SCID-only sample
because of the assumption mentioned two paragraphs
above of constant PPV and NPV in subsamples. This
assumption allows us to use the precision in the total
sample to estimate prevalence in WMH-CIDI
subsamples. As a result of this two-phase sample
advantage, the precision of estimates in the WMH-
CIDI samples increases relative to the SCID-only
sample as we move to smaller and smaller sub-
samples. Three of the four WMH-CIDI sample
designs, the exception being WMH-CIDI 10,000,
outperform the SCID-only design in estimating
prevalence in the lower part of the sample propor-
tion distribution (subsamples of 30% or less). The
SCID-only design, in comparison, outperforms all
the WMH-CIDI designs in the upper part of the
distribution (subsamples of 50% or more), but these
differences are very small. Taken together, these
results lead to the conclusion that a WMH-CIDI
sample design of 7,000–9,000 respondents with
SCID reinterviews of 800–1,800 cases (oversampling
WMH-CIDI MDE cases at a 2:1 rate compared to
non-cases) would be superior to a SCID-only design
of the same cost in maximizing the precision of life-
time SCID MDE prevalence estimates if the
assumption of constant PPV and NPV holds. In the
total sample or large subsamples, SEs are small for all
these designs, which means that the modest advan-
tage of the SCID-only design is of no substantive
significance. In smaller subsamples, the WMH-CIDI
designs have a clear advantage. It is important to
remember that SCID subsamples in WMH-CIDI
sample designs would not oversample only on MDE
but on all disorders and that the 2:1 over-sampling
into the SCID sub-sample assumed here for MDE
would vary across disorders.
The conclusion that the WMH-CIDI designs are
superior to the SCID-only design depends on the
parameters being estimated. To illustrate this point,
Figure 2 presents the results of a simulation for sex
differences in the lifetime prevalence of SCID MDE,
again assuming constant PPV. As shown there, all of
the WMH-CIDI sample designs, including WMH-
CIDI 10,000, outperform the SCID-only design
1All designs assume the actual SCID DSM-IV Lifetime Prevalence estimate of MDE (24.2%) as in the NCS-R (Kessler et al., 2003),
the actual association of CIDI symptom-level data in predicting SCID diagnoses as in the NCS-R (AUC = 0.86), and a 2:1 proportional
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Figure 1. Multiple imputed standard errors of SCID DSM-IV MDE lifetime prevalence estimates for five
hypothetical CIDI-SCID sample designs.1
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throughout the entire range of the sample proportion
distribution. All else being equal, the relative perfor-
mance of the WMH-CIDI designs compared to the
SCID-only design will increase as statistics become
more complex and true prevalence becomes smaller
because of the sample-size advantages over the
SCID-only design. However, this increased perfor-
mance is achieved at the expense of having to make
increasingly more complex implicit assumptions
about the consistency of the coefficients in the MI
prediction equations across subsamples. It is always
possible to evaluate the sensitivity of results to varia-
tions in these and other assumptions in the
simulations to deal with these uncertainties. We do
not pursue this line of investigation here, though, as
our purpose is to be illustrative rather than to present
a detailed investigation of the empirical results of
any one survey. 
Discussion
We presented an overview of the rationale, design,
and analysis plan for the WMH-CIDI clinical calibra-
tion studies. These studies are being conducted in
order to increase the clinical relevance of WMH-
CIDI community epidemiological surveys. Previous
methodological studies of fully structured diagnostic
interviews like the WMH-CIDI have attempted to
validate these instruments against a clinical gold
standard. However, our review of this literature led us
to conclude that validation of this sort is impossible
because no highly reliable and valid clinical gold
standard is available. As a result, we shifted the goal
of the WMH-CIDI methodological studies to calibra-
tion rather than validation. In other words, rather
than ask whether the diagnostic classifications in the
WMH-CIDI are ‘correct’, we asked whether they are
‘consistent’ with diagnoses obtained from a state-of-
the-art semi-structured clinician-administered
research diagnostic interview (the SCID).
Consistency is being evaluated both at the aggregate
level (consistency of prevalence estimates) and at the
individual level (concordance of prevalence esti-
mates). Conventional statistics are being calculated
to describe WMH-CIDI and SCID concordance
(sensitivity, specificity, Cohen’s κ) for purposes of
comparison with previous diagnostic validity studies.
We are also calculating several descriptive statistics
that are a function of sensitivity and specificity
1All designs assume the actual SCID DSM-IV lifetime prevalence estimates of MDE among women (23.9%) and men (24.6%) as in
the NCS-R (Kessler et al., 2003), the actual association of CIDI symptom-level data in predicting SCID diagnoses as in the NCS-R
(AUC = 0.86), consistency of this association among women and men, and a 2:1 proportional representation of SCID cases in the
clinical calibration subsample compared to the total sample.
Figure 2. Estimated standard errors of sex differences in lifetime SCID DSM-IV Major Depressive Episode
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(odds-ratio, Yule’s Q, area under the ROC curve)
that, unlike κ, are not sensitive to variation in preva-
lence when sensitivity and specificity are constant.
However, the main focus of the consistency analyses
is to embed comparisons of consistency into substan-
tive investigations. This involves creating prediction
equations in clinical calibration subsamples that are
used to assign predicted probabilities of SCID diag-
noses to each respondent who completes a
WMH-CIDI interview. Analyses of these predicted
probabilities allow us to investigate the extent to
which estimates of prevalence and correlates are
similar or different when based on WMH-CIDI diag-
noses versus predicted SCID diagnoses. Multiple
imputation is used to adjust estimates of se for the
SCID diagnoses being based on a model rather than
on observation. When the substantive results are
similar there is an advantage to focusing on WMH-
CIDI results, as they are more precise than predicted
SCID results because the WMH-CIDI is measured
for each respondent while the SCID is based on a
prediction model. When results differ, we are able to
bound our uncertainty by comparing WMH-CIDI
and SCID estimates.
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